Cetera Advisors LLC lifted its stake in shares of Aetna Inc (NYSE:AET) by 3.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 8,715 shares of the company’s stock after purchasing an additional 279 shares during the quarter. Cetera Advisors LLC’s holdings in Aetna were worth $1,573,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of AET. BlueCrest Capital Management Ltd bought a new stake in shares of Aetna during the second quarter valued at about $425,000. Advisory Services Network LLC raised its stake in shares of Aetna by 16.2% during the second quarter. Advisory Services Network LLC now owns 1,780 shares of the company’s stock valued at $270,000 after purchasing an additional 248 shares in the last quarter. Phocas Financial Corp. bought a new stake in shares of Aetna during the second quarter valued at about $182,000. Achmea Investment Management B.V. raised its stake in shares of Aetna by 5.3% during the second quarter. Achmea Investment Management B.V. now owns 33,669 shares of the company’s stock valued at $5,110,000 after purchasing an additional 1,705 shares in the last quarter. Finally, Davidson Kempner Capital Management LP bought a new stake in shares of Aetna during the second quarter valued at about $7,592,000. Institutional investors and hedge funds own 87.10% of the company’s stock.

A number of brokerages recently weighed in on AET. Piper Jaffray Companies upgraded shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price objective on the stock in a research note on Wednesday, January 3rd. Wells Fargo & Co reiterated an “outperform” rating and issued a $208.00 price target (up from $200.00) on shares of Aetna in a research report on Monday, December 4th. Morgan Stanley cut shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 price target on the stock. in a research report on Wednesday, December 20th. Deutsche Bank upgraded shares of Aetna from a “hold” rating to a “buy” rating and boosted their price target for the stock from $195.00 to $212.00 in a research report on Monday, January 22nd. Finally, ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Ten investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $185.94.

Aetna Inc (NYSE AET) opened at $176.77 on Thursday. The firm has a market capitalization of $58,365.78, a PE ratio of 30.74, a P/E/G ratio of 1.45 and a beta of 0.60. Aetna Inc has a 12 month low of $124.83 and a 12 month high of $194.40. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.68 and a quick ratio of 0.53.

Aetna (NYSE:AET) last issued its quarterly earnings results on Tuesday, January 30th. The company reported $1.25 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.18 by $0.07. The firm had revenue of $14.74 billion for the quarter, compared to analysts’ expectations of $14.79 billion. Aetna had a return on equity of 21.50% and a net margin of 3.15%. Aetna’s revenue was down 6.2% on a year-over-year basis. During the same quarter last year, the business posted $0.08 EPS. analysts expect that Aetna Inc will post 10.99 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Thursday, January 11th were paid a $0.50 dividend. The ex-dividend date of this dividend was Wednesday, January 10th. This represents a $2.00 dividend on an annualized basis and a yield of 1.13%. Aetna’s dividend payout ratio is currently 34.78%.

COPYRIGHT VIOLATION WARNING: This news story was first published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States & international copyright and trademark law. The legal version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/15/aetna-inc-aet-position-raised-by-cetera-advisors-llc.html.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.